Literature DB >> 29501822

Hot topics in necrotising skin and soft tissue infections.

Kordo Saeed1, Silvano Esposito2, Ian Gould3, Tiziana Ascione4, Matteo Bassetti5, Eric Bonnet6, Emilio Bouza7, Monica Chan8, Joshua S Davis9, Giuseppe De Simone2, Matthew Dryden10, Thomas Gottlieb11, Karolin Hijazi12, David C Lye13, Pasquale Pagliano4, Christina Petridou14, Elda Righi5, John Segreti15, Serhet Unal16, Ata Nevzat Yalcin17.   

Abstract

Entities:  

Keywords:  Gas gangrene; Intravenous immunoglobulin G; Necrotising fasciitis; Panton-Valentine leukocidin; Pyomyositis; Skin and soft tissue infections

Mesh：

Substances：

Year:  2018        PMID： 29501822     DOI： 10.1016/j.ijantimicag.2018.02.012

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

Review 1.  Anti-bacterial monoclonal antibodies: next generation therapy against superbugs.

Authors:  Hui Wang; Daijie Chen; Huili Lu
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-01       Impact factor: 4.813

2.  Necrotizing Skin and Soft Tissue Infection Due to Syncephalastrum Species and Fusarium solani Species Complex Following Open Tibia Fracture.

Authors:  Vasiliki Mamali; Christos Koutserimpas; Kassiani Manoloudaki; Olympia Zarkotou; George Samonis; Georgia Vrioni
Journal:  Diagnostics (Basel)       Date:  2022-05-07

3.  Impact of a multidisciplinary care bundle for necrotizing skin and soft tissue infections: a retrospective cohort study.

Authors:  Tomas Urbina; Camille Hua; Emilie Sbidian; Romain Bosc; Françoise Tomberli; Raphael Lepeule; Jean-Winoc Decousser; Armand Mekontso Dessap; Olivier Chosidow; Nicolas de Prost
Journal:  Ann Intensive Care       Date:  2019-10-24       Impact factor: 6.925

4.  Clostridial Gas Gangrene - A Rare but Deadly Infection: Case series and Comparison to Other Necrotizing Soft Tissue Infections.

Authors:  Maximilian Leiblein; Nils Wagner; Elisabeth H Adam; Johannes Frank; Ingo Marzi; Christoph Nau
Journal:  Orthop Surg       Date:  2020-10-04       Impact factor: 2.071
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.